VIP and hepatocellular carcinoma: Furthermore, histopathological and bioluminescence targeted organ detection analyses indicated that VIP treatment further restricted metastases formation in both groups (Fig. 3G-I), suggesting exogenous VIP treatment suppresses HCC metastasis via the activation of VIPR1.